κ-Bungarotoxin was first reported in 1983 as a component of the venom of Bungarus multicinctus that differed in biological effect from the previously known α-bungarotoxin: κ-bungarotoxin, but not α-bungarotoxin, was capable of impeding nicotinic signaling in the chickciliary ganglion.[4] Bungarotoxin toxin was designated "kappa" as an allusion to the Latin word kiliaris ("from the eye"), and to the root of "ciliary".[4] Separately identified toxins designated "toxin F" and "bungarotoxin 3.1" were identified by protein sequencing as identical to κ-bungarotoxin.[2]
κ-Bungarotoxin is a receptor antagonist, meaning it blocks the normal response of the receptor to acetylcholine, which inhibits neurotransmission and therefore causes neuromuscularparalysis. Like the α-bungarotoxins, κ-bungarotoxin causes a post-synaptic blockade of signaling; this is in contrast to the β-bungarotoxins which induce a pre-synaptic block.[3] The distinction between the effects of α-bungarotoxin and κ-bungarotoxin was first identified functionally, as differences in effects on specific neural structures.[4][6] The basis of this functional difference has been molecularly characterized as differences in receptor subtype specificity; the pentameric receptors are assembled from different distributions of subunits in neurons and in muscles.[5]
Structure
The κ-bungarotoxin polypeptide is 66 amino acids long and folds into an antiparallel beta sheet structure stabilized by five conserved disulfide bonds, a structural feature shared by many peptide toxins. Unlike other members of the bungarotoxin family, κ-bungarotoxin is a dimer.[1]
References
^ abDewan JC, Grant GA, Sacchettini JC (November 1994). "Crystal structure of kappa-bungarotoxin at 2.3-A resolution". Biochemistry. 33 (44): 13147–54. doi:10.1021/bi00248a026. PMID7947721.
^ abLoring RH, Andrews D, Lane W, Zigmond RE (October 1986). "Amino acid sequence of toxin F, a snake venom toxin that blocks neuronal nicotinic receptors". Brain Research. 385 (1): 30–7. doi:10.1016/0006-8993(86)91543-x. PMID3021284. S2CID41801981.
^ abChiappinelli VA, Weaver WR, McLane KE, Conti-Fine BM, Fiordalisi JJ, Grant GA (1996). "Binding of native kappa-neurotoxins and site-directed mutants to nicotinic acetylcholine receptors". Toxicon. 34 (11–12): 1243–56. doi:10.1016/s0041-0101(96)00110-9. PMID9027980.
^Dryer SE, Chiappinelli VA (December 1983). "Kappa-bungarotoxin: an intracellular study demonstrating blockade of neuronal nicotinic receptors by a snake neurotoxin". Brain Research. 289 (1–2): 317–21. doi:10.1016/0006-8993(83)90033-1. PMID6318897. S2CID38572091.